Influence of long-term administration of fluoxetine on cerebral threshold and muscle activity patterns in chronic stroke patients. - Influence of fluoxetine on brain and muscle activity in chronic stroke patients
- Conditions
- The effect of fluoxetine on brain excitability and muscle activation will be measured in chronic stroke patients (> 6 months after stroke). As secondary measures, also brain activation, phase-synchronization in the brain, and motor function will be studied.MedDRA version: 8.1Level: LLTClassification code 10055221Term: Ischemic stroke
- Registration Number
- EUCTR2006-005044-86-NL
- Lead Sponsor
- Roessingh Research and Development
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Authorised-recruitment may be ongoing or finished
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
First ever ischemic cortical/subcortical ischemic stroke, confirmed by CT or MRI; more than 6 months after stroke; age > 18
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
Patients suffering from another neurological disease; uncompensated hemineglect or cognitive disabilities; epilepsy, or first epileptic insult post stroke; patients with first grade relatives suffering from epilepsy; pregnancy; pacemaker; pathological heart rhythms disorders; use of antidepressants.
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method